SEC Form 4 reporting owner

Sampath Anand

Sampath Anand has filed 14 Form 4 transactions reported between January 28, 2026 and June 10, 2026, as EVP, Operations, EVP, Ops & Clinical Research of MASIMO CORP.

Name as filed: Sampath Anand

Open-market buys, 24 mo

None

reported

Open-market sales, 24 mo

$2.6M

3 lines

Companies

with Form 4 filings

Latest transaction

Jun 10, 2026

transaction date

Roles and reported holdings

MASIMASIMO CORP
Jan 28, 2026 – Jun 10, 2026
EVP, Operations, EVP, Ops & Clinical Research
Held directly40,909 sh as of Jan 28, 2026 · Form 4
24 months: $2.6M sold

Transaction history

All 14 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

Date	Company	Type	Shares	Price	Value	Owned after	Filing
Jun 10, 2026	MASIEVP, Operations	Disposition to issuerCode D · direct	3,855	$22.47	$87K@ $22.47	0	Form 4
Jun 10, 2026	MASIEVP, Operations	Disposition to issuerCode D · direct	4,422	$0.5800	$3K@ $0.5800	0	Form 4
Jun 10, 2026	MASIEVP, Operations	Disposition to issuerCode D · direct	7,235	$46.50	$336K@ $46.50	0	Form 4
Jun 10, 2026	MASIEVP, Operations	Disposition to issuerCode D · direct	10,000	$89.13	$891K@ $89.13	0	Form 4
Jun 10, 2026	MASIEVP, Operations	Disposition to issuerCode D · direct	6,840	—	—	0	Form 4
Jun 10, 2026	MASIEVP, Operations	Disposition to issuerCode D · direct	4,828	—	—	0	Form 4
Jun 10, 2026	MASIEVP, Operations	Disposition to issuerCode D · direct	5,158	—	—	0	Form 4
Jun 10, 2026	MASIEVP, Operations	Disposition to issuerCode D · direct	1,820	—	—	0	Form 4
Jun 10, 2026	MASIEVP, Operations	Disposition to issuerCode D · direct	33,901	$180.00	$6.1M@ $180.00	0	Form 4
Mar 6, 2026	MASIEVP, Operations	Grant or awardCode A · direct	6,840	—	—	6,840	Form 4
Jan 28, 2026	MASIEVP, Ops & Clinical Research	Open-market saleCode S · direct	196	$138.09	$27K@ $138.09	40,909	Form 4
Jan 28, 2026	MASIEVP, Ops & Clinical Research	Open-market saleCode S · direct	6,560	$137.22	$900K@ $137.22	41,105	Form 4
Jan 28, 2026	MASIEVP, Ops & Clinical Research	Open-market saleCode S · direct	11,924	$136.56	$1.6M@ $136.56	47,665	Form 4
Jan 28, 2026	MASIEVP, Ops & Clinical Research	Option exerciseCode M · direct	30,000	$37.84	$1.1M@ $37.84	59,589	Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.